What is Sentiar?
Sentiar operates at the intersection of digital health and medical technology, specializing in the development of advanced software platforms that leverage augmented reality and holographic visualization. The company's core offering provides clinicians with immersive, three-dimensional views of patient anatomy and catheter positioning during complex, minimally invasive procedures. By enhancing visualization and real-time guidance, Sentiar aims to improve surgical precision, streamline clinical decision-making, and ultimately support safer, more intuitive procedural outcomes for healthcare professionals. The company's focus on interventional procedures highlights its commitment to advancing the capabilities of modern medicine through cutting-edge visualization technology.
How much funding has Sentiar raised?
Sentiar has raised a total of $16.3M across 5 funding rounds:
Angel/Seed
$1.1M
Debt
$144K
Series A
$5.1M
Series B
$8.5M
Debt
$1.5M
Angel/Seed (2017): $1.1M, investors not publicly disclosed
Debt (2021): $144K led by PPP
Series A (2021): $5.1M supported by TechWald Holding S.p.A, VCapital, Keiretsu Forum, Neue Fund, Cultivation Capital, BioGenerator Company, and QRM Capital
Series B (2023): $8.5M featuring TechWald Holding SpA, VCapital, and MedVenture Partners
Debt (2026): $1.5M, investors not publicly disclosed
Key Investors in Sentiar
TechWald Holding SpA
TechWald Holding S.p.A. is an operational holding company that invests in early-stage companies focused on healthcare innovation, particularly in the MedTech industry. Their portfolio includes medical devices, equipment, and digital services aimed at benefiting patients, doctors, and healthcare systems. The company emphasizes ethical profit generation for its shareholders while supporting high growth potential in healthcare technologies. TechWald is committed to advancing medical technologies that provide significant value in the healthcare sector.
VCapital
VCapital is a Chicago-based venture capital firm focused on early-stage companies. Their strategy is to invest in companies that offer the ability for exceptional, profitable growth. Their investments span medical device, biotechnology, technology, telecommunications and more.
MedVenture Partners
MedVenture Partners is an independent company providing Corporate Finance and Strategy Advisory Services focused on the life science and health care industries and their investors. The core of our solutions is the integration of managerial and consulting methodologies with health economic evaluation techniques. We provide in-depth expert knowledge involving both the formal and informal structures of the various health care systems. Our services include: Corporate finance Economic evaluation of health technologies Corporate strategy Part-time / interim management services Our projects are usually segmented in analyzing and conceptual phases which lead to modular designed implementation phases. MedVenture Partners is focused on transaction related projects as well as on critical growth processes. Especially in companies handling with growth processes, MedVenture Partners is usually mandated for longer periods, often involved in executive tasks. We build on established local and international professional relationships within the life sciences, health care and financial communities.
What's next for Sentiar?
With the recent major strategic investment and a history of substantial capital raises, Sentiar is poised for accelerated growth and market penetration. The company's trajectory, marked by Series A and Series B financing rounds, indicates a transition from development to scaling operations. Future strategic initiatives will likely focus on expanding the adoption of its AR-based visualization solutions across a broader range of medical specialties and geographical markets. Continued investment in research and development will be crucial to maintaining its technological edge and addressing evolving clinical needs, solidifying its position as a leader in MedTech innovation.
See full Sentiar company page
